Assetmark, Inc Quest Diagnostics Inc Transaction History

Assetmark, Inc

$34.9 Billion
Q3 2024

A detailed history of Assetmark, Inc transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Assetmark, Inc holds 6,123 shares of DGX stock, worth $839,402. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,123

Previous 5,961 2.72%

Holding current value

$839,402

Previous $815,000 2.94%

% of portfolio

0.0%

Previous 0.0%

36 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$137.09 - $137.09 $22,208 - $22,208	162 Added 2.72%	6,123 $839,000
Q2 2024 Aug 13, 2024	BUY	$125.91 - $144.34 $47,342 - $54,271	376 Added 6.73%	5,961 $815,000
Q1 2024 May 06, 2024	SELL	$123.78 - $142.11 $25,127 - $28,848	-203 Reduced 3.51%	5,585 $743,000
Q4 2023 Feb 09, 2024	BUY	$120.62 - $141.12 $84,313 - $98,642	699 Added 13.74%	5,788 $798,000
Q3 2023 Oct 27, 2023	BUY	$121.86 - $144.92 $149,156 - $177,382	1,224 Added 31.67%	5,089 $620,000
Q2 2023 Aug 11, 2023	BUY	$130.56 - $146.84 $20,889 - $23,494	160 Added 4.32%	3,865 $543,000
Q1 2023 May 05, 2023	BUY	$131.53 - $155.76 $17,230 - $20,404	131 Added 3.67%	3,705 $524,000
Q4 2022 Feb 10, 2023	BUY	$123.31 - $157.26 $26,511 - $33,810	215 Added 6.4%	3,574 $559,000
Q3 2022 Nov 01, 2022	BUY	$121.77 - $141.1 $5,236 - $6,067	43 Added 1.3%	3,359 $412,000
Q2 2022 Aug 03, 2022	SELL	$127.07 - $145.39 $20,839 - $23,843	-164 Reduced 4.71%	3,316 $441,000
Q1 2022 May 13, 2022	SELL	$129.09 - $164.35 $51.5 Million - $65.6 Million	-399,171 Reduced 99.14%	3,480 $476,000
Q4 2021 Feb 14, 2022	BUY	$140.36 - $173.01 $56 Million - $69 Million	398,651 Added 9966.28%	402,651 $69.7 Million
Q3 2021 Nov 12, 2021	BUY	$132.95 - $158.0 $54,243 - $64,464	408 Added 11.36%	4,000 $581,000
Q2 2021 Aug 16, 2021	BUY	$126.66 - $141.48 $80,555 - $89,981	636 Added 21.52%	3,592 $474,000
Q1 2021 May 14, 2021	BUY	$114.63 - $133.34 $1,834 - $2,133	16 Added 0.54%	2,956 $379,000
Q4 2020 Feb 10, 2021	SELL	$112.7 - $128.05 $57,815 - $65,689	-513 Reduced 14.86%	2,940 $350,000
Q3 2020 Nov 13, 2020	BUY	$107.05 - $130.01 $120,538 - $146,391	1,126 Added 48.39%	3,453 $395,000
Q2 2020 Aug 11, 2020	BUY	$73.34 - $122.61 $116,683 - $195,072	1,591 Added 216.17%	2,327 $265,000
Q1 2020 May 12, 2020	BUY	$75.14 - $115.68 $10,820 - $16,657	144 Added 24.32%	736 $59,000
Q4 2019 Feb 11, 2020	SELL	$100.29 - $107.99 $300 - $323	-3 Reduced 0.5%	592 $63,000
Q3 2019 Nov 13, 2019	SELL	$97.85 - $107.42 $1,272 - $1,396	-13 Reduced 2.14%	595 $64,000
Q2 2019 Aug 14, 2019	BUY	$85.18 - $101.94 $340 - $407	4 Added 0.66%	608 $62,000
Q1 2019 May 14, 2019	SELL	$80.68 - $89.92 $8,068 - $8,992	-100 Reduced 14.2%	604 $54,000
Q4 2018 Feb 13, 2019	BUY	$79.75 - $108.38 $14,753 - $20,050	185 Added 35.65%	704 $59,000
Q3 2018 Nov 13, 2018	SELL	$105.42 - $114.99 $843 - $919	-8 Reduced 1.52%	519 $56,000
Q2 2018 Aug 01, 2018	SELL	$97.35 - $113.14 $3,601 - $4,186	-37 Reduced 6.56%	527 $58,000
Q1 2018 May 16, 2018	SELL	$96.42 - $107.88 $87,645 - $98,062	-909 Reduced 61.71%	564 $57,000
Q4 2017 Feb 13, 2018	BUY	$90.86 - $100.24 $77,957 - $86,005	858 Added 139.51%	1,473 $145,000
Q3 2017 Nov 08, 2017	SELL	$91.96 - $108.35 $11,495 - $13,543	-125 Reduced 16.89%	615 $58,000
Q2 2017 Aug 15, 2017	BUY	N/A	119 Added 19.16%	740 $82,000
Q1 2017 Sep 15, 2017	SELL	N/A	-10,438 Reduced 94.38%	621 $61,000
Q4 2016 Sep 15, 2017	BUY	N/A	10,317 Added 1390.43%	11,059 $1.02 Million
Q3 2016 Sep 15, 2017	BUY	N/A	287 Added 63.08%	742 $63,000
Q2 2016 Sep 15, 2017	SELL	N/A	-477 Reduced 51.18%	455 $37,000
Q1 2016 Sep 15, 2017	BUY	N/A	46 Added 5.19%	932 $67,000
Q4 2015 Sep 15, 2017	BUY	N/A	886	886 $63,000

Others Institutions Holding DGX

# of Institutions

933

Shares Held

93.8M

Call Options Held

501K

Put Options Held

238K

View Full List

About QUEST DIAGNOSTICS INC

Ticker DGX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 113,887,000
Market Cap $15.6B
Description
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...

More about DGX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Assetmark, Inc with notifications on news.

Account